Maradei E - Search Results

Year	Number of Results
1993	1
1994	1
1995	2
1998	2
2000	1
2001	2
2004	2
2006	1
2007	2
2008	5
2009	8
2010	2
2011	2
2012	2
2013	3
2014	3
2015	1
2017	2
2018	1
2019	1
2020	2
2021	1
2024	0

1

Non-discriminatory Exclusion Testing as a Tool for the Early Detection of Foot-and-Mouth Disease Incursions.

Eschbaumer M, Vögtlin A, Paton DJ, Barnabei JL, Sanchez-Vazquez MJ, Pituco EM, Rivera AM, O'Brien D, Nfon C, Brocchi E, Bakkali Kassimi L, Lefebvre DJ, Navarro López R, Maradei E, Duffy SJ, Loitsch A, De Clercq K, King DP, Zientara S, Griot C, Beer M. Eschbaumer M, et al. Among authors: maradei e. Front Vet Sci. 2020 Nov 19;7:552670. doi: 10.3389/fvets.2020.552670. eCollection 2020. Front Vet Sci. 2020. PMID: 33330684 Free PMC article. Review.

2

Quantitative risk analysis applied to innocuity and potency tests on the oil-adjuvanted vaccine against foot and mouth disease in Argentina.

Cané BG, Rodríguez Toledo J, Falczuk A, Leanes LF, Manetti JC, Maradei E, Verde P. Cané BG, et al. Among authors: maradei e. Rev Sci Tech. 1995 Dec;14(4):1097-119. Rev Sci Tech. 1995. PMID: 8639949 Free article. Review. English, Spanish.

3

Challenges in foot-and-mouth disease virus strain selection as an input to attain broad vaccine intraserotype cross-protection.

Bergmann IE, Malirat V, Pedemonte A, Maradei E. Bergmann IE, et al. Among authors: maradei e. Expert Rev Vaccines. 2021 Jan;20(1):13-22. doi: 10.1080/14760584.2021.1877137. Epub 2021 Feb 1. Expert Rev Vaccines. 2021. PMID: 33455492

4

FMD vaccine matching: Inter laboratory study for improved understanding of r₁ values.

Willems T, De Vleeschauwer A, Perez-Filgueira M, Li Y, Ludi A, Lefebvre D, Wilsden G, Statham B, Haas B, Mattion N, Robiolo B, Beascoechea Perez C, Maradei E, Smitsaart E, La Torre J, De Clercq K. Willems T, et al. Among authors: maradei e. J Virol Methods. 2020 Feb;276:113786. doi: 10.1016/j.jviromet.2019.113786. Epub 2019 Nov 22. J Virol Methods. 2020. PMID: 31765721 Free article.

5

Antigenic and immunogenic spectrum of foot-and-mouth disease vaccine strain O₁ Campos against representative viruses of topotypes that circulated in Asia over the past decade.

Galdo Novo S, Malirat V, Maradei ED, Espinoza AM, Smitsaart E, Pedemonte AR, Mattion N, Bergmann IE. Galdo Novo S, et al. Among authors: maradei ed. Vaccine. 2017 Apr 25;35(18):2303-2307. doi: 10.1016/j.vaccine.2017.03.026. Epub 2017 Mar 23. Vaccine. 2017. PMID: 28343779

6

Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology.

Mattion N, Goris N, Willems T, Robiolo B, Maradei E, Beascoechea CP, Perez A, Smitsaart E, Fondevila N, Palma E, De Clercq K, La Torre J. Mattion N, et al. Among authors: maradei e. Vaccine. 2009 Jan 29;27(5):741-7. doi: 10.1016/j.vaccine.2008.11.026. Epub 2008 Nov 27. Vaccine. 2009. PMID: 19041355

7

Early adaptive immune responses in the respiratory tract of foot-and-mouth disease virus-infected cattle.

Pega J, Bucafusco D, Di Giacomo S, Schammas JM, Malacari D, Capozzo AV, Arzt J, Pérez-Beascoechea C, Maradei E, Rodríguez LL, Borca MV, Pérez-Filgueira M. Pega J, et al. Among authors: maradei e. J Virol. 2013 Mar;87(5):2489-95. doi: 10.1128/JVI.02879-12. Epub 2012 Dec 19. J Virol. 2013. PMID: 23255811 Free PMC article.

8

Protective effects of high-potency FMDV O₁ Manisa monovalent vaccine in cattle challenged with FMDV O/SKR/2010 at 7 or 4 days post vaccination.

Horsington J, Perez CB, Maradei E, Novo SG, Gonzales JL, Singanallur NB, Bonastre P, Vosloo W. Horsington J, et al. Among authors: maradei e. Vaccine. 2017 Sep 12;35(38):5179-5185. doi: 10.1016/j.vaccine.2017.07.102. Epub 2017 Aug 5. Vaccine. 2017. PMID: 28789849

9

Reducing animal experimentation in foot-and-mouth disease vaccine potency tests.

Reeve R, Cox S, Smitsaart E, Beascoechea CP, Haas B, Maradei E, Haydon DT, Barnett P. Reeve R, et al. Among authors: maradei e. Vaccine. 2011 Jul 26;29(33):5467-73. doi: 10.1016/j.vaccine.2011.05.056. Epub 2011 Jun 2. Vaccine. 2011. PMID: 21640777

10

Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests.

Robiolo B, La Torre J, Maradei E, Beascoechea CP, Perez A, Seki C, Smitsaart E, Fondevila N, Palma E, Goris N, De Clercq K, Mattion N. Robiolo B, et al. Among authors: maradei e. Vaccine. 2010 Aug 31;28(38):6235-41. doi: 10.1016/j.vaccine.2010.07.012. Epub 2010 Jul 17. Vaccine. 2010. PMID: 20643090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

40 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year